A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Preliminary results Meeting Abstract

  

Authors:	Slovin, S. F.; Kargman, M.; Durso, R.; Curley, T.; Israel, R. J.; Olson, W. C.; Morris, S.; Murphy, D.; Scher, H. I.
Abstract Title:	A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Preliminary results
Meeting Title:	2011 Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	29
Issue:	7 Suppl.
Meeting Dates:	2011 Feb 17-19
Meeting Location:	Orlando, FL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2011-03-01
Language:	English
ACCESSION:	WOS:000208880700141
DOI:	10.1200/jco.2011.29.7_suppl.140
PROVIDER:	wos
Notes:	Meeting Abstract: 140 -- Source: Wos